A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND Treatment studies are lacking for patients with bipolar II disorder (BDII). The objective of this study was to compare lamotrigine (LTG) and lithium (Li) monotherapy for the treatment of BDII depression. METHODS Patients with BDII acute depression were randomized to open-label monotherapy with LTG or Li, and evaluated by trained raters blinded to treatment. Patients were titrated to 200 mg/day of LTG over 8 weeks or at least 900 mg/day of Li over 2 weeks (serum level 0.6-1.2 mEq/L), and seen biweekly for 16 weeks. The primary outcome variable was change in the Hamilton Depression Rating Scale 17-item (Ham-D(17)), evaluated using mixed effects random regression. RESULTS Both groups showed significant improvement from baseline to endpoint on the Ham-D(17) (p<0.0001), with no between group differences (p=0.95). Seventy-two percent of the population was rapid cycling by DSM-IV criteria. No differences in response were noted between rapid cyclers and non-rapid cyclers. Early termination for any cause was 42%. The Li group reported significantly more side effects, although drop-out due to side effects did not differ between groups. LIMITATIONS This study was limited by an open treatment design, a lack of placebo arm, and uneven treatment groups. CONCLUSIONS Lamotrigine and lithium were effective monotherapy for BDII depression, with comparable response and remission rates. Naturalistic design and lack of placebo limit conclusions, though patient history indicated long standing depression unlikely to be alleviated by time. Patients who received Li reported more side effects, but this did not appear to impact drop-out rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744 · cited 6×
“Statistics Ham-D17, MADRS, YMRS, CGI-BP, and GAF assessments were analyzed using mixed effects random regression (Gibbons et al, 1993).”
InfluentialMerikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Judd, L. L., Akiskal, H. S., Schettler, P. J., Coryell, W., Endicott, J., Maser, J. D., Solomon, D. A., Leon, A. C., & Keller, M. B. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.3.261 · Cited by 1,243 · cited 1×
“It has recently been recognized that for patients with BDII, a significantly greater proportion of time over the course of the illness is spent in the depressive vs. hypomanic phase of the illness, with subjects spending up to 50.3% of their time depressed (Judd et al, 2003; Kupka et al, 2007).”
InfluentialCalabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883 · cited 3×
“An uncontrolled, prospective clinical evaluation of patients with BDI and BDII on Li maintenance treatment followed patients for an average of 6.35 years and found that the average time to relapse for patients with BDI was 17 months while the average time to relapse for patients with BDII was 100 months (Tondo et al,…”
InfluentialForcing a sequential experiment to be balanced
EFRON, B. (1971) · Biometrika · doi:10.1093/biomet/58.3.403 · Cited by 873
Thase, M. E., Macfadden, W., Weisler, R. H., Chang, W., Paulsson, B., Khan, A., & Calabrese, J. R. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000248603.76231.b7 · Cited by 559 · cited 1×
“Of note, the relative degree of improvement on either Li or LTG was consistent with that seen on drug for the recently reported placebo-controlled, acute depression studies of quetiapine in BDI and BDII (Calabrese et al, 2005; Thase et al, 2006).”
Calabrese, J. R., Suppes, T., Bowden, C. L., Sachs, G. S., Swann, A. C., McElroy, S. L., Kusumakar, V., Ascher, J. A., Earl, N. L., Greene, P. L., et al. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1106 · Cited by 498
Self-citationA Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00004 · Cited by 446
Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder 1
Kupka, R. W., Altshuler, L. L., Nolen, W. A., Suppes, T., Luckenbaugh, D. A., Leverich, G. S., Frye, M. A., Keck, P. E., McElroy, S. L., Grunze, H., et al. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00467.x · Cited by 397 · cited 1×
“It has recently been recognized that for patients with BDII, a significantly greater proportion of time over the course of the illness is spent in the depressive vs. hypomanic phase of the illness, with subjects spending up to 50.3% of their time depressed (Judd et al, 2003; Kupka et al, 2007).”
InfluentialSelf-citationKane, J. M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090053011 · Cited by 212 · cited 2×
“…trials of BDII only using Li, these findings support early acute and maintenance findings for a role for Li in the treatment of bipolar depression (Kane et al, 1982; Zornberg and Pope, 1993; Greil and Kleindienst, 1999), suggesting an early acute efficacy maintained into the continuation…”
Research works printed but not linked: 17
- Akiskal, 1996, The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV, J. Clin. Psychopharmacol., 16, 4, 10.1097/00004714-199604001-00002 · DOI · Paper page
- Angst, 1998, The emerging epidemiology of hypomania and bipolar II disorder, J. Affect. Disord., 50, 143, 10.1016/S0165-0327(98)00142-6 · DOI · Paper page
- Bowden, 2005, Treatment options for bipolar depression, J. Clin. Psychiatry, 66, 3
- Friedman, 2006, Seasonal changes in clinical status in bipolar disorder: a prospective study in 1000 STEP-BD patients, Acta Psychiatr. Scand., 113, 510, 10.1111/j.1600-0447.2005.00701.x · DOI · Paper page
- Geddes, 2007, Lamotrigine for acute treatment of bipolar depression: individual patient data meta-analysis of five randomized, placebo-controlled trials, Bipolar Disord., 9, 42
- Gibbons, 1993, Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset, Arch. Gen. Psychiatry, 50, 739, 10.1001/archpsyc.1993.01820210073009 · DOI · Paper page
- Greil, 1999, Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified, Int. Clin. Psychopharmacol., 14, 283, 10.1097/00004850-199914050-00003 · DOI
- Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
- Kraemer, 1981, Coping strategies in psychiatric clinical research, J. Consult. Clin. Psychol., 49, 309, 10.1037/0022-006X.49.3.309 · doi:10.1037/0022-006x.49.3.309
- Montgomery, 1979, A new depression scale designed to be sensitive to change, Br. J. Psychiatry, 134, 382, 10.1192/bjp.134.4.382 · DOI · Paper page
- Schaffer, 2006, Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression, J. Affect. Disord., 96, 95, 10.1016/j.jad.2006.05.023 · DOI
- Smith, 2007, Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials, Bipolar Disord., 9, 394, 10.1111/j.1399-5618.2007.00490.x · DOI · Paper page
- Soares-Weiser, 2007, A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder, Health Technol. Assess., 11, 1, 10.3310/hta11390 · DOI · Paper page
- Spearing, 1997, Modification of the clinical global Impression scale for use in bipolar illness (BP): the CGI-BP, Psychiatry Res., 73, 159, 10.1016/S0165-1781(97)00123-6 · DOI · Paper page
- Tondo, 1998, Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders, Am. J. Psychiatry, 155, 638, 10.1176/ajp.155.5.638 · DOI · Paper page
- Weisler, 2007, Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence, J. Affect. Disord., 108, 1, 10.1016/j.jad.2007.09.012 · DOI
- Zornberg, 1993, Treatment of depression in bipolar disorder: new directions for research, J. Clin. Psychopharmacol., 13, 397, 10.1097/00004714-199312000-00005 · DOI · Paper page
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
“Additional supporting data come from a single-blinded trial which showed that lithium was as effective as lamotrigine in treating BDII depression over 6 weeks (445).”
BackgroundSelf-citationYatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Yatham, L. N., Kennedy, S. H., Schaffer, A., Parikh, S. V., Beaulieu, S., O'Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00672.x · Cited by 570
(2011) · doi:10.2165/11586970-000000000-00000 · Cited by 225
A systematic review of the evidence on the treatment of rapid cycling bipolar disorder
Fountoulakis, K. N., Kontis, D., Gonda, X., & Yatham, L. N. (2013) · Bipolar Disorders · doi:10.1111/bdi.12045 · Cited by 80
Metadata
- Authors
- Suppes, T., Marangell, L. B., Bernstein, I. H., Kelly, D. I., Fischer, E. G., Zboyan, H. A., Snow, D. E., Martinez, M., Al Jurdi, R., Shivakumar, G., Sureddi, S., & Gonzalez, R.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 111
- Issue
- 2-3
- Pages
- 334-343
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W1966884017
- Cited by
- 96
- References
- 12
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- National Institute of Mental Health (1 R21 MH067055-01A1)
- GlaxoSmithKline
- Stanley Medical Research Institute (02T-158)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. https://app.cochat.ai/papers/10.1016/j.jad.2008.02.004
- The paper
- Suppes, T., Marangell, L. B., Bernstein, I. H., Kelly, D. I., Fischer, E. G., Zboyan, H. A., Snow, D. E., Martinez, M., Al Jurdi, R., Shivakumar, G., Sureddi, S., & Gonzalez, R. (2008). A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2008.02.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.